USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bio-rad Europe Gmbh

USPTO PatentsView assignee record - 26 granted patents across 12 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

13.1

Avg claims per patent

+280%

5-year grant velocity

The verdict

According to USPTO PatentsView, Bio-rad ranks #11,573 of 50,000 tracked US assignees by granted-patent volume, with 26 patents across 12 technology areas.

#11,573
of 50,000 US assignees by volume: Top 27%
by Innovation Score (44.0/100): 13.1
avg claims per patent: +280%
grant velocity, last 5 yrs

Portfolio overview

Bio-rad Europe Gmbh has been granted 26 US utility patents between 2018 and 2025, placing Bio-rad Europe Gmbh at #11,573 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.1 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Bio-rad Europe Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Bio-rad sits between Bullfrog International, LC (26 patents, rank #11,575) and Brilliant Home Technology, Inc. (26 patents, rank #11,583) - the closest US assignees by grant volume. The composite Innovation Score of 44.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 19 grants, compared with 5 in the 2015–2019 window, a +280% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Bio-rad Europe Gmbh's 13.1 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 12 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Bullfrog Internat…

26
Bard Shannon

26
Baumueller Nuernb…

26
Belden

26
Biosig

26
Bock 1 & KG

26
Braze

26
Brilliant Home Te…

26
Bio-rad Europe ◀

26

What this shows Bio-rad holds 26 patents at rank #11,579, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bio-rad

By rank, the assignees closest to #11,579 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Bio-rad's primary technology class.

Bio-rad's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Bio-rad Europe Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	3.8%
2019	4	15.4%
2020	2	7.7%
2021	2	7.7%
2022	5	19.2%
2023	2	7.7%
2024	8	30.8%
2025partial year	2	7.7%

Which technologies does Bio-rad Europe Gmbh patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 22

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 7

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 6

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 3

C07K - PEPTIDES 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 2

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 2

C12Y - ENZYMES 2

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 1

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 1

B67B - APPLYING CLOSURE MEMBERS TO BOTTLES JARS, OR SIMILAR CONTAINERS; OPENING CLOSED CONTAINERS 1

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 1

Top 12 of 12 technology areas

Grant record at a glance

Portfolio Volume 26 grants

CPC subclasses 12

Avg. claims / grant 13.1

Velocity +280%

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#11,573

of 50,000 tracked assignees

Innovation Score

44.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does Bio-rad Europe Gmbh rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bio-rad Europe Gmbh ranks #11,573 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bio-rad Europe Gmbh hold?

Bio-rad Europe Gmbh holds 26 US utility patents granted between 2018 and 2025, spanning 12 technology areas.

What is Bio-rad Europe Gmbh's Innovation Score?

Bio-rad Europe Gmbh has an Innovation Score of 44.0 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bio-rad Europe Gmbh focus on?

Bio-rad Europe Gmbh's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 22 patents. Grants appear in 12 CPC subclasses total.

Is Bio-rad Europe Gmbh's patent grant rate increasing or decreasing?

Bio-rad Europe Gmbh's recent grant velocity is +280% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Bio-rad Europe Gmbh's patents?

Bio-rad Europe Gmbh's patents average 13.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bio-rad Europe Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Bio-rad's 26 grants land it in the top 27% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Bio-rad ranks #11,573 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.